Literature DB >> 30230297

New insight in penile cancer.

Michele Marchioni1, Francesco Berardinelli2, Cosimo De Nunzio3, Philippe Spiess4, Francesco Porpiglia5, Luigi Schips1, Luca Cindolo6.   

Abstract

Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is based on self-examination, clinical examination and confirmatory biopsy. Several imaging techniques could be used for staging purposes. However, the best modality for staging in intermediate and high-risk patients is by surgical evaluation and the use of inguinal lymph node dissection, that has also a therapeutic effect. Unfortunately, inguinal lymph node dissection is underused. Penile cancer treatment may have a major adverse impact on urinary and sexual function and on quality of life. Penile-sparing surgery and radiation therapies are available, and in selected patients offer good outcomes with acceptable rates of local recurrence. Penile-sparing surgery should be preferred when indicated. Follow-up with periodical controls is mandatory up to 5 years. However, risk of local, nodal and distant recurrence after 5 years was reported. Imaging is not routinely recommended during follow-up. Patients should be trained to self-examination during the follow-up.

Entities:  

Mesh:

Year:  2018        PMID: 30230297     DOI: 10.23736/S0393-2249.18.03215-0

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  8 in total

Review 1.  Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy.

Authors:  George Coba; Trushar Patel
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

2.  Trends in Incidence, Mortality, and Survival of Penile Cancer in the United States: A Population-Based Study.

Authors:  Xinxi Deng; Yang Liu; Xiangpeng Zhan; Tao Chen; Ming Jiang; Xinhao Jiang; Luyao Chen; Bin Fu
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

3.  Radical penectomy, a compromise for life: results from the PECAD study.

Authors:  Jamil Ghahhari; Michele Marchioni; Philippe E Spiess; Juan J Chipollini; Peter Nyirády; Judith Varga; Pasquale Ditonno; Stefano Boccasile; Giulia Primiceri; Cosimo De Nunzio; Giorgia Tema; Andrea Tubaro; Alessandro Veccia; Alessandro Antonelli; Gennaro Musi; Ottavio De Cobelli; Andrea Conti; Stefano Puliatti; Salvatore Micali; Mario Álvarez-Maestro; José Quesada Olarte; Erico Diogenes; Marcos Venicio Alves Lima; Andrew Tracey; Georgi Guruli; Riccardo Autorino; Petros Sountoulides; Roman Sosnowski; Luigi Schips; Luca Cindolo
Journal:  Transl Androl Urol       Date:  2020-06

Review 4.  Squamous Cell Carcinoma Antigen: Clinical Application and Research Status.

Authors:  Huange Zhu
Journal:  Diagnostics (Basel)       Date:  2022-04-24

5.  Total Urethra and Penile Shaft Reconstruction with Combined Pedicled Anterolateral Thigh Flap and Radial Forearm Free Flap after Total Penectomy.

Authors:  Pietro Giovanni di Summa; Gianluca Sapino; Olivier Bauquis
Journal:  Arch Plast Surg       Date:  2022-05-27

6.  Research and Clinical Significance of the Differentially Expressed Genes TP63 and LMO4 in Human Immunodeficiency Virus-Related Penile Squamous Cell Carcinoma.

Authors:  Wenrui Xue; Xin Zheng; Xiaopeng Hu; Yu Zhang
Journal:  Am J Mens Health       Date:  2021 Mar-Apr

7.  Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population-based study.

Authors:  Xiangpeng Zhan; Luyao Chen; Ming Jiang; Bin Fu
Journal:  Cancer Med       Date:  2022-03-03       Impact factor: 4.711

8.  The prognostic value of lymph node ratio in comparison to positive lymph node count in penile squamous cell carcinoma.

Authors:  Jiajie Yu; Qian Long; Zhiqiang Zhang; Shufen Liao; Fufu Zheng
Journal:  Int Urol Nephrol       Date:  2021-09-28       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.